Bright Minds Biosciences Inc.
DRUG
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.11% | 57.98% | -2.74% | -3.73% | 850.34% |
| Total Receivables | 23.60% | 48.37% | 23.02% | 248.71% | 25.27% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 27.21% | 36.56% | 85.96% | 55.77% | 11.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.39% | 57.64% | -2.00% | -3.17% | 813.06% |
|
|
|||||
| Total Current Assets | 9.39% | 57.64% | -2.00% | -3.17% | 813.06% |
| Net Property, Plant & Equipment | -16.42% | -15.01% | -12.00% | -12.60% | 41.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.36% | 57.46% | -2.02% | -3.20% | 798.21% |
|
|
|||||
| Total Accounts Payable | -14.98% | 227.88% | -2.35% | 47.67% | -13.92% |
| Total Accrued Expenses | -88.17% | 3,217.09% | 85.71% | -40.57% | -65.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.93% | 5.93% | 5.91% | 7.13% | -14.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -31.16% | 277.95% | -0.05% | 38.34% | -18.02% |
|
|
|||||
| Total Current Liabilities | -31.16% | 277.95% | -0.05% | 38.34% | -18.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -58.78% | -35.79% | -25.40% | -19.22% | 161.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -31.64% | 248.42% | -3.16% | 27.28% | -5.54% |
|
|
|||||
| Common Stock & APIC | 12.73% | 34.22% | 5.41% | 1.09% | 135.95% |
| Retained Earnings | -18.09% | -7.33% | -20.22% | -8.71% | 6.24% |
| Treasury Stock & Other | 25.76% | 19.24% | 50.13% | -0.20% | -34.63% |
| Total Common Equity | 10.55% | 55.00% | -2.01% | -3.50% | 880.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.55% | 55.00% | -2.01% | -3.50% | 880.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.55% | 55.00% | -2.01% | -3.50% | 880.70% |
|
|
|||||